作者:Marco T. Rudolf、Thorsten Kaiser、Andreas H. Guse、Georg W. Mayr、Carsten Schultz
DOI:10.1002/jlac.199719970909
日期:1997.9
All six isomeric myo-inositol pentakisphosphates (InsP5), consisting of the two meso compounds myo-inositol 1,3,4,5,6-pentakisphosphate [Ins(1,3,4,5,6)P5] (18) and myo-inositol 1,2,3,4,6-pentakisphosphate [Ins(1,2,3,4,6)P5] (22) and two pairs of enantiomers myo-inositol 1,2,4,5,6-pentakisphosphate [Ins(1,2,4,5,6)P5] (15) myo-inositol 2,3,4,5,6-pentakisphosphate [Ins(2,3,4,5,6)P5] (ent-15) and myo-inositol
所有六种异构体肌肌醇pentakisphosphates(INSP 5),由两个的内消旋化合物肌醇肌醇1,3,4,5,6- pentakisphosphate【INS(1,3,4,5,6)p 5 ](18)和肌肌醇1,2,3,4,6- pentakisphosphate【INS(1,2,3,4,6)p 5 ](22)和两对对映体的MYO肌醇1,2,4,5- ,6- pentakisphosphate【INS(1,2,4,5,6)p 5 ](15)肌醇肌醇2,3,4,5,6- pentakisphosphate【INS(2,3,4,5,6-) P 5 ](ent - 15)和myo-肌醇1,2,3,5,6-五磷酸[Ins(1,2,3,5,6)P 5 ](20)肌醇-肌醇1,2,3,4,5-五磷酸[Ins(1分别合成了(2,3,4,5)P 5 ](ent - 20)。这些化合物已在组织中发现,